Michael Ackermann - Aug 6, 2021 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role
Director
Signature
/s/ Leonard M. Greenstein, Attorney-in-Fact
Stock symbol
TARS
Transactions as of
Aug 6, 2021
Transactions value $
-$95,725
Form type
4
Date filed
8/10/2021, 04:55 PM
Previous filing
Aug 6, 2021
Next filing
Aug 12, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARS Common Stock Sale -$78.2K -3.13K -0.25% $25.00 1.23M Aug 6, 2021 Direct F1
transaction TARS Common Stock Sale -$17.5K -700 -0.06% $25.00 1.23M Aug 9, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2021.